Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.28−0.01 (-3.78%)
Close on Nov 11, 2026Market cap $1.74MP/E –Yield –
Co-Diagnostics operating margin
Operating margin is operating income as a percentage of revenue.
Co-Diagnostics's operating margin for the twelve months ending Sep 30, 2026 was -5614.3%. For fiscal 2025 it was -8058.8%, against -1023.7% the year before. The highest annual figure on record is 55.9% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8058.8% | −7035.1 |
| FY2024 | Dec 31, 2024 | -1023.7% | −396.8 |
| FY2023 | Dec 31, 2023 | -626.9% | −548.1 |
| FY2022 | Dec 31, 2022 | -78.8% | −125.9 |
| FY2021 | Dec 31, 2021 | 47.1% | −8.9 |
| FY2020 | Dec 31, 2020 | 55.9% | +2797.5 |
| FY2019 | Dec 31, 2019 | -2741.6% | +12587.0 |
| FY2018 | Dec 31, 2018 | -15328.6% | +44238.9 |
| FY2017 | Dec 31, 2017 | -59567.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -2216.2% | +2608.2 |
| Q2 FY2026 | Jun 30, 2026 | -3732.5% | +1213.7 |
| Q1 FY2026 | Mar 31, 2026 | -6309.1% | +10700.6 |
| Q4 FY2025 | Dec 31, 2025 | -10056.7% | −2082.8 |
| Q3 FY2025 | Sep 30, 2025 | -4824.5% | −3228.1 |
| Q2 FY2025 | Jun 30, 2025 | -4946.1% | −4657.1 |
| Q1 FY2025 | Mar 31, 2025 | -17009.7% | −14816.8 |
| Q4 FY2024 | Dec 31, 2024 | -7973.9% | −7641.3 |
| Q3 FY2024 | Sep 30, 2024 | -1596.4% | −1232.7 |
| Q2 FY2024 | Jun 30, 2024 | -289.1% | +5774.7 |
| Q1 FY2024 | Mar 31, 2024 | -2192.9% | −539.8 |
| Q4 FY2023 | Dec 31, 2023 | -332.6% | +1531.2 |
| Q3 FY2023 | Sep 30, 2023 | -363.7% | −235.4 |
| Q2 FY2023 | Jun 30, 2023 | -6063.7% | −5981.2 |
| Q1 FY2023 | Mar 31, 2023 | -1653.0% | −1696.3 |
| Q4 FY2022 | Dec 31, 2022 | -1863.8% | −1914.4 |
| Q3 FY2022 | Sep 30, 2022 | -128.3% | −173.6 |
| Q2 FY2022 | Jun 30, 2022 | -82.6% | −125.7 |
| Q1 FY2022 | Mar 31, 2022 | 43.3% | −8.3 |
| Q4 FY2021 | Dec 31, 2021 | 50.5% | −8.5 |
| Q3 FY2021 | Sep 30, 2021 | 45.3% | −9.9 |
| Q2 FY2021 | Jun 30, 2021 | 43.1% | −18.1 |
| Q1 FY2021 | Mar 31, 2021 | 51.6% | +121.5 |
| Q4 FY2020 | Dec 31, 2020 | 59.0% | +1554.4 |
| Q3 FY2020 | Sep 30, 2020 | 55.2% | +4037.6 |
| Q2 FY2020 | Jun 30, 2020 | 61.2% | +2279.3 |
| Q1 FY2020 | Mar 31, 2020 | -69.9% | +36827.0 |
| Q4 FY2019 | Dec 31, 2019 | -1495.3% | +15350.8 |
| Q3 FY2019 | Sep 30, 2019 | -3982.4% | +13176.9 |
| Q2 FY2019 | Jun 30, 2019 | -2218.1% | +11739.9 |
| Q1 FY2019 | Mar 31, 2019 | -36896.8% | −23722.0 |
| Q4 FY2018 | Dec 31, 2018 | -16846.1% | +40647.8 |
| Q3 FY2018 | Sep 30, 2018 | -17159.3% | +52319.5 |
| Q2 FY2018 | Jun 30, 2018 | -13958.0% | +14466.7 |
| Q1 FY2018 | Mar 31, 2018 | -13174.8% | – |
| Q4 FY2017 | Dec 31, 2017 | -57493.8% | – |
| Q3 FY2017 | Sep 30, 2017 | -69478.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -28424.7% | – |
See a number that looks wrong?